Daily Brief United States: Essential Minerals Acquisition, GE Vernova , US 2Y, Crude Oil, Nexalin Technology , Specificity, F45 Training Holdings , BirchBioMed, City Therapeutics and more

• Essential Minerals Acquisition Corp. (ESMA US) is a newly organized blank check company incorporated in the Cayman Islands, formed to execute a merger, share exchange, asset acquisition, or business combination targeting precious metals and critical minerals assets of strategic importance to the United States, primarily within Tier-1 jurisdictions including Nevada, Texas, Australia, and Canada.
• The vehicle is structured around a $150.0 million initial public offering (15.0 million units at $10.00/unit, excluding the 2.25 million unit over-allotment option), featuring 100% gross proceeds collateralized in a US Treasury-backed trust account and a 1/8th Class A share right per unit, which eliminates traditional warrant exercise friction while reducing long-term capital overhang.
• Led by junior mining and natural resource capital markets executives Matthew Hayes (Chairman/CEO) and Michael Loughnan (CFO), the company targets mid-market enterprises valued between $500.0 million and $1.5 billion; institutional assessment rests on de-SPAC execution probability, target asset quality, and managing 20% founder promote dilution against secular supply-chain reshoring tailwinds.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Electrification equipment pricing leverage has structurally inverted historical margin dynamics, pushing 1H 2026 segment EBITDA margins to 18.2% as high-voltage equipment scarcity allows GEV to pass through input inflation while expanding backlog gross margins.
• Offshore wind tail risk remains under-reserved for structural mechanical fatigue, where current warranty provisions address known manufacturing lot defects (e.g., Gaspé blade bonding) but fail to capture potential fleet-wide blade root retrofits on the Haliade-X platform.
• Gas Power slot reservations reaching 116 GW in Q2 2026 and customer advance payments drove a record $5.1 billion in single-quarter free cash flow, temporarily masking long-term utility working capital stretch through unprecedented upfront cash collection.

• The EUR/USD seagull was salvaged at 3 pips against 19.5 paid after the 16 September hike, having been marked +181% on 21 August. The USD/INR short expired flat at 95.98.
• The euro trade paid on fiscal dominance, not the US front end we entered on. We overrode the Iran exit rule because we read misread a three-week regime
• FCNR carried the INR through a 20% rise in oil, but faltered as prices soared 37%. We still see US disinflation in the data, and think 3 hikes are rich.

• NYMEX ULSD prices continue to succumb to government intervention, this time in response to President Trump’s deal for Russian diesel.     
• We do not believe the agreement will have a sustainable impact on diesel prices over the next few months, however. The price impact of the G7 release was fleeting.            
• In response to the Russian deal, we would anticipate that Ukraine will intensify its attacks against Russian refinery assets, despite President Trump’s call for a ceasefire on energy assets.                 

• Essential Minerals Acquisition Corp filed its S-1 registration statement in late August 2026, seeking to raise $150.0 million via 15.0 million units at $10.00 per unit to acquire critical and precious mineral assets in North America with enterprise values between $500.0 million and $1.5 billion.
• The PIPE market for blank-check transactions in the natural resources sector remains highly constrained, requiring equity bridge structures, debt-like preferred instruments, or royalty monetization to fill 60.0% to 70.0% of total capital requirements for projects transitioning from feasibility to construction.
• Long development lead times—averaging 12.0 to 15.0 years from initial discovery to commercial operation—force SPAC sponsors to bypass greenfield exploration assets in favor of advanced-stage, fully permitted domestic projects with existing Definitive Feasibility Studies (DFS).

• Commercial traction remains constrained by zero insurance reimbursement and low volume, with Q2 2026 revenue printing at just $12.16 thousand despite international distribution agreements.
• The company faces an acute balance sheet wall: with roughly $1.0 million in cash as of mid-2026 against a quarterly cash burn of $1.7 million to $1.8 million, raising capital is an immediate operational requirement.
• While Nasdaq minimum bid price compliance was restored in October 2026 via a 1-for-30 reverse stock split, the business must satisfy Nasdaq’s $2.5 million stockholders’ equity requirement by January 4, 2027, forcing near-term dilutive equity or non-dilutive licensing choices.

• Specificity, Inc. is a Nevada-incorporated digital marketing firm providing hyper-targeted solutions to businesses and agencies through three service offerings.
• The company reported total revenue increased approximately 10% to $1,090,450 for the year ended December 31, 2025, and generated international revenues for the first time.
• The company reports net losses, an accumulated deficit, and a working capital deficit, with its independent auditor expressing substantial doubt about its ability to continue as a going concern.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Severe Operational Retrenchment and Revenue Contraction: After an aggressive global expansion culminating in an initial public offering in July 2021, F45 Training Holdings Inc. (FXLV) encountered severe operational and financial dislocation. Full-year FY2022 revenue contracted 22.1% year-over-year to $104.42M (down from $134.02M in FY2021) as third-party franchisee financing facilities collapsed, new studio delivery stalled, and extensive accounting restatements revealed widespread premature revenue recognition.
• Acute Solvency Distress, Dilution Overhang, and NYSE Delisting: The company reported massive net losses of -$178.80M in FY2022 and -$182.72M in FY2021, driven by negative operating cash flows (-$96.78M in FY2022) and free cash flow burn of -$103.30M. This liquidity strain prompted emergency debt restructurings, executive turnover, internal control failures, and a voluntary delisting from the New York Stock Exchange in August 2023 to the over-the-counter Expert Market tier, virtually eliminating institutional liquidity.
• Distressed Turnaround Pivot Under New Brand Leadership: Operating under new Chief Executive Officer Tom Dowd and Chief Brand Officer Mark Wahlberg, F45 is attempting a stabilization strategy focused on unit-level franchisee economics, recurring royalty cash generation, overhead rationalization, and brand extensions such as FS8 (Pilates/Yoga). However, extreme balance sheet debt, ongoing litigations, and lingering franchisee attrition limit near-term institutional investability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• BirchBioMed Inc. is a clinical stage biopharmaceutical company developing treatments for scarring, skin disorders, autoimmune diseases, and organ fibrosis.
• BirchBioMed completed a Phase 1 clinical trial for FS2 in 2018 and received U.S. FDA Orphan Drug Designation for FS2 in November 2025.
• The company reported cash and cash equivalents of $3,086,484 as of June 30, 2026, alongside a net loss of $(1,249,402) for the six months then ended.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• City Therapeutics, Inc. is a clinical-stage biotechnology company developing RNA interference therapeutics to silence disease-relevant proteins, leveraging its City Platform.
• City Therapeutics advanced three programs into or toward the clinic since July 2023, with CITY-FXI Phase 1 data showing 85% FXI knockdown.
• The company reported collaboration revenue of $6,358 thousand for six months ended June 30, 2026, alongside a net loss of $(53,443) thousand.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.